COMD News

Events and Research in Speech, Language, and Hearing Disorders

  • Disclaimer

    These news items are gleaned from over 500 sources on the Internet and are provided as a service to our patrons. The University of Texas at Dallas does not guarantee the veracity, reliability or completeness of any information provided on this page, in the comments, or in any hyperlink appearing on this page

  • Callier Center News

    Program to Help Families Facing Autism Challenge

    Reaching out to families touched by autism, the UT Dallas Callier Center for Communication Disorders is offering a pilot program to help parents facing a child's new diagnosis.

    Strategy Training and Response to Therapy (START) focuses on children 18 months to 5 years old who have been recently diagnosed with an autism spectrum disorder and who have received an autism assessment through Children’s Medical Center of Dallas..

    Read the rest of the story at the UTD News Center

    A Cure For Tinnitus at UTD?

    A promising new therapy has made its way from Australia to the States. The Callier Center for Communication Disorders at University of Texas at Dallas is one of about 200 medical centers offering Neuromonics, a treatment device for tinnitus developed by an Australian audiologist, Dr. Paul Davis.

    Dallas audiologist Anne Howell, head of Callier's tinnitus clinic, says the treatment works by retraining neural pathways in the brain. As a result, the auditory system is desensitized to the sound.

    Read the rest of the story at The Dallas Observer
  • Archives

  • Note:

    These news items are gleaned from over 500 sources on the Internet and are provided as a service to our patrons. The University of Texas at Dallas does not guarantee the veracity, reliability or completeness of any information provided on this page, in the comments, or in any hyperlink appearing on this page

  • Pages

  •  

    March 2008
    S M T W T F S
    « Feb   Apr »
     1
    2345678
    9101112131415
    16171819202122
    23242526272829
    3031  
  • Meta

Prednisone Treatment for Vestibular Neuritis

Posted by Callier Library on March 26, 2008

from Otology & Neurotology

Objective: To evaluate the value of corticosteroids in the treatment of vestibular neuritis (VN).

Design: Prospective controlled randomized.

Methods: Thirty VN patients, 15 in the study and 15 in the control group, were the subjects of the study. The study group was treated by 1 mg/kg prednisone for 5 days, followed by gradually reduced doses of prednisone for an additional 15 days, and vestibular sedatives for symptomatic relief during the first 5 days after presentation. The control group received a placebo and similar vestibular sedatives. The patients had a baseline evaluation and follow-up examinations after 1, 3, 6, and 12 months. The groups were compared for the presence of symptoms and signs, caloric lateralization on the electronystagmography (ENG), the presence of other pathologic findings in the ENG, and Dizziness Handicap Inventory scores.

Results: No differences were found between the groups in the occurrence of symptoms and signs, degree of caloric lateralization, presence of other ENG pathologic findings, and Dizziness Handicap Inventory scores at the end of the study. Complete resolution was observed in 64% of the study and in 80% of the control group. The study group showed earlier recovery of ENG lateralization at the 1- and 3-month follow-up evaluations and higher rates of complete resolution at the 3- and 6-month follow-up points.

Conclusion: Prednisone therapy might enhance earlier recovery but does not improve the long-term prognosis of VN. The clinical and laboratory parameters in VN are not correlated, and both are required for complete patient evaluation.

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <pre> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>